[1] This powerful duo represents a safe, science-backed approach to supplementation that addresses multiple aspects of athleticism
Selective peptide use: Choose single most relevant peptide (Cerebrolysin for glaucoma, GHK-Cu for AMD, BPC-157 for injury)
Semaglutide at a dose of 2.4 mg has established weight-loss and cardiovascular benefits, and cagrilintide at a dose of 2.4 mg has shown promising results in early-phase trials
F., Papaconstantinou, J., Fry, C
Taking all this data together it seems logical or appropriate to conclude that, because IGF1-R has a different signalling pathway that can maintain lipid oxidation in the liver, FFA uptake in muscle, and activates mTORC1 could reactivate IR through tyrosine kinase activity on IRS, thus displacing serine phosphorylation, reinstituting insulin signalling